MELANIE SHAH: Open Payments
NPI 1467615591 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,678 in 45 payments from 9 companies in 2025. Trend: 2023 $325 · 2024 $422 · 2025 $1,678
Food & beverage: $1,599Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $446 |
| GlaxoSmithKline, LLC. | 13 | $402 |
| Actelion Pharmaceuticals US, Inc. | 3 | $245 |
| Viatris Specialty LLC | 4 | $191 |
| Verona Pharma, Inc. | 5 | $126 |
| Regeneron Healthcare Solutions, Inc. | 1 | $109 |
| GENZYME CORPORATION | 2 | $58 |
| Amgen Inc. | 2 | $53 |
| Grifols USA, LLC | 2 | $47 |
Products named: NUCALA, YUPELRI, FASENRA, DUPIXENT, UPTRAVI, Ohtuvayre, BREZTRI, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
